Establishment of Monoclonal Antibody PMab-202 Against Horse Podoplanin

Podoplanin (PDPN), a type I transmembrane glycoprotein, is expressed in several body tissues, including podocytes of renal glomerulus, type I alveolar cells of lung, and lymphatic endothelial cells. PDPN activates platelet aggregation by binding to C-type lectin-like receptor-2 (CLEC-2) presented on...

Full description

Saved in:
Bibliographic Details
Published inMonoclonal antibodies in immunodiagnosis and immunotherapy Vol. 37; no. 5; p. 233
Main Authors Furusawa, Yoshikazu, Yamada, Shinji, Itai, Shunsuke, Sano, Masato, Nakamura, Takuro, Yanaka, Miyuki, Handa, Saori, Mizuno, Takuya, Maeda, Ken, Fukui, Masato, Harada, Hiroyuki, Kaneko, Mika K, Kato, Yukinari
Format Journal Article
LanguageEnglish
Published United States 01.11.2018
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Podoplanin (PDPN), a type I transmembrane glycoprotein, is expressed in several body tissues, including podocytes of renal glomerulus, type I alveolar cells of lung, and lymphatic endothelial cells. PDPN activates platelet aggregation by binding to C-type lectin-like receptor-2 (CLEC-2) presented on platelets. Monoclonal antibodies (mAbs) against human-, mouse-, rat-, rabbit-, dog-, bovine-, and cat-PDPN have already been established. However, anti-horse PDPN mAbs have not yet been developed. In this study, we immunized mice with synthetic horse PDPN peptides and developed anti-horse PDPN mAbs. One of the established mAbs, PMab-202 (IgG , kappa), was specifically able to detect horse PDPN in Chinese hamster ovary/horse PDPN (CHO/horPDPN) cells in flow cytometry experiments. PMab-202 was also able to detect endogenous horse PDPN expressed in and a horse kidney cell line, FHK-Tcl3.1, in flow cytometry and Western blot analyses. PMab-202 is expected to prove useful in investigating the function of horse PDPN.
ISSN:2167-9436
DOI:10.1089/mab.2018.0030